(IN BRIEF) Sanofi’s mRNA vaccine candidate for chlamydia has been granted fast track designation by the US FDA, reflecting its promising potential to address a significant public health issue. Designed to protect against primary and recurrent infections caused by Chlamydia … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged asymptomatic infection, chlamydia, Chlamydia trachomatis, Fast Track Designation, Griffith University, immunogenicity, infertility, Jean-François Toussaint, mRNA vaccine candidate, pelvic inflammatory disease, phase 1/2 clinical study, pregnancy complications, public health need, Queensland Government, safety, Sanofi, Translational Science Hub, University of Queensland, US Food and Drug Administration
(PRESS RELEASE) Sophia Antipolis Cedex, France, 29-Mar-2021 — /EuropaWire/ — European Society of Cardiology (ESC) announces that its online scientific congress EHRA 2021 will be held 23 to 25 April online. Highlights of the congress are the latest practice-changing research … Read the full press release
Posted in Artificial Intelligence (AI), Education, France, Healthcare, Internet & Online, News, Science, Technology
Tagged ablation procedure, apps, arrhythmias, artificial-intelligence, atrial fibrillation treatment, blood pressure, Cancer, cannabis, cardiac arrest, cardiac arrhythmia, cardiac devices, congenital heart diseases, defibrillator, Drones, EHRA, EHRA 2021, electrophysiology, ESC, European Heart Rhythm Association, European Society of Cardiology, GeneralAtrial Fibrillation, heart disorders, heart rate, heart rhythm, heart rhythm disorders, ICD, implantable cardioverter defibrillator, mental health, pregnancy complications, Professor Isabelle Van Gelder, scientific congress, smartwatches, sudden cardiac arrest, Weight loss
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?